Zobrazeno 1 - 3
of 3
pro vyhledávání: '"G. M. Argoud"'
Autor:
T. W. Littlejohn, G. Garcia-Soria, Sherwyn Schwartz, G. M. Argoud, X. Li, H.-P. Guler, J. M. Cherrington, Craig A. Bennett, G. Gonzalez-Galvez, A. M. O’Farrell, M. Gerstman
Publikováno v:
Diabetes, obesitymetabolism. 10(4)
Aim To determine the efficacy and tolerability of PHX1149, a novel dipeptidyl peptidase-4 (DPP4) inhibitor, in patients with type 2 diabetes. Methods This is a multicentre, randomized, double-blind, placebo-controlled, 4-week study in patients with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b1b38e6b8cfb958ff140aa62405ed0
https://pubmed.ncbi.nlm.nih.gov/18333888
https://pubmed.ncbi.nlm.nih.gov/18333888
Publikováno v:
Diabetes. 36:959-962
This study addressed the controversial question of whether a negative—insulin-feedback loop exists in vivo. We utilized prehepatic insulin production, calculated by computerized deconvolution analysis of peripheral C-peptide concentration, as a mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d84f40e5e89b1df21f0262f6b225dca6
https://doi.org/10.2337/diab.36.8.959
https://doi.org/10.2337/diab.36.8.959
Publikováno v:
The American journal of physiology. 252(5 Pt 1)
Although negative hepatic glucose production rates are physiologically impossible, they have been observed when hepatic glucose production is measured with the tracer-dilution technique during the hyperinsulinemic, euglycemic glucose clamp. Because h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04a583ef2f5df8a4aa7140c89d7a025
https://pubmed.ncbi.nlm.nih.gov/3555113
https://pubmed.ncbi.nlm.nih.gov/3555113